Markets › India › NSE › SOLARA

Solara Active Pharma Sciences Ltd

NSE:SOLARAHealthcare

₹645.65−7.33%At closeAt close · Mon 19 Oct · ≈ AED 24.91 · Market cap $351.65M · Next earnings Wed 11 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	23.9%	44.2%	8.7%	−10.1%	51.2%	26.7%	—	—
Operating margin	16.4%	−2.6%	0.6%	−29.9%	34.7%	6.4%	6.4%	+0.0 pts
Net margin	13.9%	−4.6%	−1.6%	−44.0%	0.0%	−0.5%	−0.5%	+0.0 pts
EBITDA margin	25.9%	6.3%	10.7%	−21.9%	16.1%	13.6%	—	—
Return on equity	13.9%	−3.8%	−1.5%	−60.8%	0.0%	−0.6%	−0.6%	+0.0 pts
Return on assets	8.5%	−2.0%	−0.8%	−24.1%	0.0%	−0.3%	−0.3%	+0.0 pts
Return on capital employed	14.3%	−1.8%	0.5%	−34.8%	34.6%	6.1%	—	—
Debt / equity	0.4×	0.7×	0.7×	1.1×	0.7×	0.5×	0.5×	−0.2%
Debt / assets	23.8%	35.1%	34.9%	43.0%	35.7%	29.4%	—	—
Interest coverage	3.1×	−0.5×	0.1×	−3.7×	3.9×	0.9×	—	—
Current ratio	1.3×	1.2×	1.1×	0.6×	0.8×	1.0×	1.0×	+0.0%
Quick ratio	1.0×	0.6×	0.6×	0.4×	0.4×	0.6×	—	—
Cash ratio	0.3×	0.0×	0.0×	0.0×	0.0×	0.1×	0.1×	+0.0%
Asset turnover	0.6×	0.4×	0.5×	0.5×	0.6×	0.6×	—	—
Inventory turnover	4.1×	1.2×	2.3×	3.9×	2.0×	3.2×	—	—
Receivables turnover	3.3×	2.6×	2.7×	3.7×	3.9×	3.1×	—	—
Dividend payout	8.9%	−18.5%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.